Media & Press

BioSpace: Emergex Announces Authorisation from Philippines FDA to Initiate Phase I-II Clinical Trial of CoronaTcP™

January 3, 2024
|
Emergex
BioSpace: Emergex Announces Authorisation from Philippines FDA to Initiate Phase I-II Clinical Trial of CoronaTcP™
Read the full article here:
Biospace

Keep up with the latest updates and features in the world of investing, deep tech, and more. Curated by Vickers.

Buy Canopy
About Us
Our ChangemakersOur AdvantageWho We AreOur Commitment
Connect
Contact UsVickers PulseMedia & PressLinkedInSearch
Legal
Terms & Conditions
Sign up for our quarterly newsletter.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Quarterly emails – No spam ever.
Copyright © Vickers Venture Partners
Site by Noro & Sün